For patients with MET exon 14-altered NSCLC, Tepmetko was associated with frequent side effects, although the safety profile is considered manageable.

As the prostate cancer treatment landscape continues to evolve, understanding the risks and benefits of each approach is critical for patients.

Receiving a “Stand Up to Cancer Day” email gave me the strength to support a friend through her darkest cancer days.

Dr. Josh Sabari and Max Doppelt explore challenges in trial enrollment and the potential of emerging therapies to offer hope ...

That is what standing up to cancer means to me: not just surviving, but living fully, deeply, and purposefully, showing the ...

For patients with advanced non-small cell lung cancer who progressed on two or more prior regimens, THIO with Libtayo ...

Perioperative immunotherapy for the treatment of non-small cell lung cancer is starting to exhibit survival benefits among ...

Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer ...

This guide is designed to help you understand liver cancer and equip you with the right questions to ask your medical team.

The FDA has accepted a new drug application for relacorilant as a treatment for patients with platinum-resistant ovarian ...

As a 12-year pancreatic cancer survivor, I share my journey through diagnosis, treatment and survival, hoping my story ...

Susan G. Komen is marking a significant milestone in the effort to improve care and outcomes for people facing inflammatory ...